Encephalomyocarditis Virus 2A Protein Inhibited Apoptosis by Interaction with Annexin A2 through JNK/c-Jun Pathway

Encephalomyocarditis virus can cause myocarditis and encephalitis in pigs and other mammals, thus posing a potential threat to public health safety. The 2A protein is an important virulence factor of EMCV. Previous studies have shown that the 2A protein may be related to the inhibition of apoptosis by virus, but its specific molecular mechanism is not clear. In this study, the 2A protein was expressed in Escherichia coli in order to find interacting cell proteins. A pull down assay, coupled with mass spectrometry, revealed that the 2A protein possibly interacted with annexin A2. Co-immunoprecipitation assays and confocal imaging analysis further demonstrated that the 2A protein interacted with annexin A2 in cells. In reducing the expression of annexin A2 by siRNA, the ability of the 2A protein to inhibit apoptosis was weakened and the proliferation of EMCV was slowed down. These results suggest that annexin A2 is closely related to the inhibition of apoptosis by 2A. Furthermore, both RT-PCR and western blot results showed that the 2A protein requires annexin A2 interaction to inhibit apoptosis via JNK/c-Jun pathway. Taken together, our data indicate that the 2A protein inhibits apoptosis by interacting with annexin A2 via the JNK/c-Jun pathway. These findings provide insight into the molecular pathogenesis underlying EMCV infection.

[1]  K. Hajjar,et al.  Annexin A2 in Inflammation and Host Defense , 2020, Cells.

[2]  Hongbin He,et al.  Annexin A2 gene interacting with viral matrix protein to promote bovine ephemeral fever virus release , 2020, Journal of veterinary science.

[3]  K. Kuča,et al.  Selective inhibitors for JNK signalling: a potential targeted therapy in cancer , 2020, Journal of enzyme inhibition and medicinal chemistry.

[4]  Gang Wang,et al.  GroEL Protein (Heat Shock Protein 60) of Mycoplasma gallisepticum Induces Apoptosis in Host Cells by Interacting with Annexin A2 , 2019, Infection and Immunity.

[5]  H. Chee,et al.  Annexin A2 extracellular translocation and virus interaction: A potential target for antivirus‐drug discovery , 2019, Reviews in medical virology.

[6]  H. Chee,et al.  Annexin II as a Dengue Virus Serotype 2 Interacting Protein Mediating Virus Interaction on Vero Cells , 2019, Viruses.

[7]  W. Kast,et al.  Annexin A2 in Virus Infection , 2018, Front. Microbiol..

[8]  U. Rescher,et al.  Annexins in Translational Research: Hidden Treasures to Be Found , 2018, International journal of molecular sciences.

[9]  Hualan Chen,et al.  Annexin A2 (ANXA2) interacts with nonstructural protein 1 and promotes the replication of highly pathogenic H5N1 avian influenza virus , 2017, BMC Microbiology.

[10]  H. Liu,et al.  Annexin A2 contributes to cisplatin resistance by activation of JNK-p53 pathway in non-small cell lung cancer cells , 2017, Journal of Experimental & Clinical Cancer Research.

[11]  S. Winfree,et al.  The Annexin A2/p11 complex is required for efficient invasion of Salmonella Typhimurium in epithelial cells , 2014, Cellular microbiology.

[12]  K. Hajjar,et al.  Annexin A2 System in Human Biology: Cell Surface and Beyond , 2013, Seminars in Thrombosis & Hemostasis.

[13]  Yi-Ting Fang,et al.  Annexin A2 Silencing Induces G2 Arrest of Non-small Cell Lung Cancer Cells through p53-dependent and -independent Mechanisms* , 2012, The Journal of Biological Chemistry.

[14]  M. Carocci,et al.  The encephalomyocarditis virus , 2012, Virulence.

[15]  N. Cordonnier,et al.  Encephalomyocarditis Virus 2A Protein Is Required for Viral Pathogenesis and Inhibition of Apoptosis , 2011, Journal of Virology.

[16]  A. Palmenberg,et al.  Mutational analysis of the EMCV 2A protein identifies a nuclear localization signal and an eIF4E binding site. , 2011, Virology.

[17]  V. Agol,et al.  Viral security proteins: counteracting host defences , 2010, Nature Reviews Microbiology.

[18]  Volker Gerke,et al.  Annexins – unique membrane binding proteins with diverse functions , 2004, Journal of Cell Science.

[19]  A. Rizzino,et al.  Specific down-regulation of annexin II expression in human cells interferes with cell proliferation , 1999, Molecular and Cellular Biochemistry.

[20]  Bonnie F. Sloane,et al.  Cell surface complex of cathepsin B/annexin II tetramer in malignant progression. , 2000, Biochimica et biophysica acta.

[21]  K. Hajjar,et al.  Annexin II: a mediator of the plasmin/plasminogen activator system. , 1999, Trends in cardiovascular medicine.

[22]  D. Aunis,et al.  Annexin II in exocytosis: catecholamine secretion requires the translocation of p36 to the subplasmalemmal region in chromaffin cells , 1996, The Journal of cell biology.